Related Experiment Video

Updated: Jun 14, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in

J A Pulikkan1, V Dengler, A A Peer Zada

  • 1State Center for Cell and Gene Therapy, Department of Oncology and Hematology, Martin Luther University Halle-Wittenberg, Halle, Germany.

Leukemia
|April 9, 2010
PubMed

Insights

Mutant CCAAT enhancer-binding protein alpha (C/EBPalpha) in acute myeloid leukemia (AML) increases PIN1 expression, blocking myeloid differentiation. Inhibiting PIN1 promotes differentiation, suggesting a potential AML treatment strategy.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cancer Research

Background:

  • CCAAT enhancer-binding protein alpha (C/EBPalpha) is a transcription factor crucial for granulopoiesis.
  • Loss of C/EBPalpha function in leukemic cells causes myeloid differentiation arrest and contributes to leukemia development.
  • Mutations in C/EBPalpha are observed in approximately 9% of acute myeloid leukemia (AML) patients.

Purpose of the Study:

  • To elucidate the mechanism by which the mutant C/EBPalpha-p30 protein causes differentiation block in AML.
  • To investigate the role of PIN1 as a target of C/EBPalpha-p30 in AML pathogenesis.
  • To explore the therapeutic potential of targeting PIN1 in AML with C/EBPalpha mutations.

Main Methods:

  • Proteomic screening to identify C/EBPalpha-p30 targets.
  • Analysis of PIN1 expression in leukemic patient samples.
  • Investigation of E2F1 recruitment to the PIN1 promoter.
  • Assessment of myeloid differentiation upon PIN1 inhibition or overexpression.
  • Evaluation of PIN1's effect on c-Jun protein stability and ubiquitination.

Main Results:

  • C/EBPalpha-p30 was found to induce PIN1 expression in AML.
  • Elevated PIN1 levels were observed in leukemic patient samples.
  • C/EBPalpha-p30 recruits E2F1 to the PIN1 promoter, enhancing its expression.
  • Inhibition of PIN1 restored myeloid differentiation in primary AML blasts with C/EBPalpha mutations.
  • PIN1 overexpression blocked granulocyte differentiation, and stabilized c-Jun protein, which inhibits C/EBPalpha-mediated differentiation.

Conclusions:

  • The C/EBPalpha-p30 mutant promotes AML by inducing PIN1, which blocks granulocyte differentiation.
  • PIN1 inhibition represents a promising therapeutic strategy for AML patients harboring C/EBPalpha mutations.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...